Výsledky vyhledávání - "George Oliviera"

Y-90-Ibritumomab Tiuxetan, Fluadarabine and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for High-Risk B-Cell Lymphoma

Autor: George Oliviera, Kathrine Guthrie, Joseph G. Rajendran, John M. Pagel, Oliver W. Press, Ajay K. Gopal, Rainer Storb, David G. Maloney

Publikováno v: Blood. 116:33-33

Abstract 33 Purpose: Non-myeloablative allogeneic transplantation (NMAT) can provide prolonged remissions in patients with advanced B-cell lymphoma (B-NHL) via the graft versus lymphoma (GVL) effect, though inferior results are seen in patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::77ee89cc7f2bab1b57c53861e3666907
https://doi.org/10.1182/blood.v116.21.33.33

Zobrazit plný text záznamu

Pulse High-Dose Vorinostat Can Be Delivered with Rituximab, Ifosphamide, Carboplatin, and Etoposide In Patients with Relapsed Lymphoma: Final Results of a Phase I Trial

Autor: Lihua E. Budde, Ted Gooley, Andrei R. Shustov, Tara Chen, Thomas A. Warr, Oliver W. Press, Michelle M. Zhang, John M. Pagel, George Oliviera, Thomas E. Boyd, Ajay K. Gopal

Publikováno v: Blood. 116:2790-2790

Abstract 2790 Background: The development of more effective front-line regimens for lymphoma (e.g. R-CHOP, BEACOPP) has resulted in lower response rates to salvage regimens such as Ifosphamide, Carboplatin, Etoposide +/− Rituximab (RICE/ICE) and im

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::110a67e747fc7fb0229541d25a90a9bc
https://doi.org/10.1182/blood.v116.21.2790.2790

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání